1)	Landis, SH., Murray, T., Bolden, S. and Wing, P.A., (1998). Cancer statistics, 1998. CA. Cancer J. Clin. 48: 6-29.
2)	Jemal, A., Tiwari, R.C., Murray, T., Ghafoor, A., Samuels, A., Ward, E., Feuer, E. J. and Thun, M. J. (2004). Cancer statistics. CA. Cancer J. Clin. 54: 8-29.
3)	Reagan-Shaw, S. and Ahmad, N., (2005). Silencing of polo-like kinase (Plk) 1 via siRNA causes induction of apoptosis and impairment of mitosis machinery in human prostate cancer cells: implications for the treatment of prostate cancer. FASEB. J. 19: 611-613.
4)	Talcott, J.A., Rieker, P., Clark, J.A., Propert, K.J., Weeks, J.C., Beard, C.J., Wishnow, K.I., Kaplan, I., Loughlin, K.R., Richie, J.P. and Kantoff, P.W. (1998). Patient-reported symptoms after primary therapy for early prostate cancer: Results of a prospective cohort study. J. Clin. Oncol. 16: 275-283.
5)	Quinn, M. and Babb, P. (2002). Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: International comparisons. BJU. Int. 90: 162-164.
6)	Herbert, J.R., Ghumare, S.S. and Gupta, P.C. (2006). Stage at diagnosis and relative differences in breast and prostrate cancer incidence in India: Comparison with the United States. Asian. Pac. J. Cancer. Prev. 7: 547-555.
7)	Daskivich, T.J. and Oh, W.K. (2006). Failure of gonadotropin-releasing hormone agonists with and without sterile abscess formation at depot sites: insight into mechanisms? Urology 67: 15-17.
8)	Gallagher, E. and Gapstur, R. (2006). Hormone-refractory prostrate cancer : A shifting paradigm in treatment. Clin. J. Oncol. Nurs. 10: 233-240.
9)	Golsteyn, R.M., Schultz, S.J., Bartek, J., Ziemiecki, A., Ried, T. and Nigg, E.A. (1994). Cell cycle analysis and chromosomal localization of human Plk1, a putative homologue of the mitotic kinases Drosophila polo and Saccharomyces cerevisiae Cdc5. J. Cell Sci. 107: 1509-1517.
10)	Glover, D.M., Hagan, I.M. and Tavares, A.A. (1998). Polo-like kinases: A team that plays throughout mitosis. Genes Dev. 12: 3777-3787.
11)	Donaldson, M.M., Tavares, A.A., Ohkura, H., Deak, P. and Glover, D.M., (2001b). Metaphase arrest with centromere separation in polo mutants of Drosophila. J. Cell Biol. 153: 663-676.
12)	Lane, H.A. and Nigg, E.A. (1996). Antibody microinjection reveals an essential role for human polo-like kinase 1 (Plk1) in the functional maturation of mitotic centrosomes. J. Cell Biol. 135(6 Pt 2): 1701-1713.
13)	Alexandru, G., Uhlmann, F., Mechtler, K., Poupart, M. A. and Nasmyth, K. (2001). Phosphorylation of the cohesin subunit Scc1 by Polo/Cdc5 kinase regulates sister chromatid separation in yeast. Cell. 105:  459-472.
14)	Sumara, I., Vorlaufer, E., Stukenberg, P.T., Kelm, O., Redemann, N., Nigg, E.A. and Peters, J.M. (2002). The dissociation of cohesin from chromosomes in prophase is regulated by polo-like kinase. Mol. Cell 9: 515-525.
15)	Lansing,T.J., McConnell, R.T., Duckett, D.R., Spehar, G.M., Knick, V.B., Hassler, D.F., Noro, N., Furuta, M., Emmitte, K.A. and Gilmer, T.M. (2007). In vitro biological activity of a novel small-molecule inhibitor of polo-like kinase 1. Mol. Cancer Ther.  6: 450-459.
16)	van Vugt, M.A., Bras, A. and Medema, R.H. (2004a). Polo-like kinase-1 controls recovery from a G2 DNA damage-induced arrest in mammalian cells. Mol. Cell. 15: 799-811.
17)	van Vugt, M.A., van de Weerdt, B.C., Vader, G., Janssen, H., Calafat, J., Klompmaker, R., Wolthuis, R.M. and Medema, R.H. (2004b). Polo-like kinase-1 is required for bipolar spindle formation but is dispensable for anaphase promoting complex/Cdc20 activation and initiation of cytokinesis. J. Biol. Chem. 279: 36841-36854.
18)	McInnes, C., Mezna, M. and Fischer, P.M. (2005). Progress in the discoveryof polo-like kinase inhibitors. Curr. Top. Med. Chem. 5: 181-197. 
19)	McInnes, C., Mazumdar, A., Mezna, M., Meades, C., Midgley, C., Scaerou, F., Carpenter, L., Mackenzie, M., Taylor, P. and Walkinshaw, M. (2006). Inhibitors of Polo-like kinase reveal roles in spindle-pole maintenance. Nat. Chem. Biol. 2(11): 608-617.
20)	Seong, Y.S., Kamijo, K., Lee, J.S., Fernandez, E., Kuriyama, R., Miki, T. and Lee, K.S. (2002). A spindle checkpoint arrest and a cytokinesis failure by the dominant-negative polo-box domain of Plk1 in U-2 OS cells. J. Biol. Chem. 277(35): 32282-32293.
21)	Leung, G.C., Hudson, J.W., Kozarova, A., Davidson, A., Dennis, J.W. and Sicheri, F. (2002). The Sak polo-box comprises a structural domain sufficient for mitotic subcellular localization. Nat. Struct. Biol. 9: 719-724.
22)	Golsteyn, R.M., Mundt, K.E., Fry, A.M. and Nigg, E.A. (1995). Cell cycle regulation of the activity and subcellular localization of Plk1, a human protein kinase implicated in mitotic spindle function. J. Cell Biol. 129(6): 1617-1628.
23)	Hamanaka, R., Smith, M.R., O'Connor, P.M., Maloid, S., Mihalic, K., Spivak, J.L., Longo, D.L. and Ferris, D.K. (1995). Polo-like kinase is a cell cycle-regulated kinase activated during mitosis. J. Biol. Chem. 270(36): 21086-21091.
24)	Hamanaka, R., Maloid, S., Smith, M.R., O'Connell, C.D., Longo, D.L. Ferris, D.K. (1994). Cloning and characterization of human and murine homologues of the Drosophila polo serine-threonine kinase. Cell. Growth. Differ. 5(3): 249-257.
25)	Holtrich, U., Wolf, G., Brauninger, A., Karn, T., Bohme, B., Rubsamen-Waigmann, H. and Strebhardt, K. (1994). Induction and down-regulation of PLK, a human serine/threonine kinase expressed in proliferating cells and tumors. Proc. Natl. Acad. Sci. USA. 91: 1736- 1740.
26)	Smith, M.R., Wilson, M.L. and Hamanaka, R. (1997). Malignant transformation of mammalian cells initiated by constitutive expression of the polo-like kinase. Biochem. Biophys. Res. Commun. 234: 397-405.
27)	Zhang, C., Pei, J., Kumar, D., Sakabe, I., Boudreau, H.E., Gokhale, P.C. and Kasid, U.N. (2007). Antisense oligonucleotides: target validation and development of systemically delivered therapeutic nanoparticles. Methods. Mol. Biol. 361:163-185.
28)	Spänkuch, B., Steinhauser, I., Wartlick, H., Kurunci-Csacsko, E., Strebhardt, K.I., Langer, K. (2008). Downregulation of Plk1 expression by receptor mediated uptake of antisense oligonucleotide-loaded nanoparticles. Neoplasia 10(3): 223-234.
29)	Sui, G., Soohoo, C., Affar, B., Gay, F., Shi, Y. and Forrester, W.C. (2002). A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc. Natl. Acad. Sci. USA. 99: 5515-5520.